Author Archive > jacquie

Provenge available for men with advanced prostate cancer at Roswell Park

» 15 February 2011 » In Hormone refractory, Immunotherapy, Metastatic, PCa Treatments, Prostate Cancer, Provenge, Vaccines » Comments Off

February 7 2011, BUFFALO, NY — The nation’s first FDA-approved cancer treatment vaccine, Provenge (sipuleucel-T), is being offered for the first time in Western New York at Roswell Park Cancer Institute (RPCI). The vaccine is designed for men with advanced prostate cancer who have limited treatment options and who meet eligibility requirements.

Continue reading...

Tags: , , ,

How does a robotic prostatectomy work?

» 15 February 2011 » In Laparoscopic surgery, Prostate Cancer, Radical Prostatectomy, Robotic surgery » Comments Off

Robot assisted prostate surgery, known medically as the da Vinci prostatectomy, has had a profound influence over treatment during the past decade. Robotic surgical technology was first developed by the military for use in the battlefield. However during the past decade, this technology has been rapidly applied to the general medical setting, notably in the field of prostate cancer.

Continue reading...

Tags: , ,

Dendreon Sets Provenge Price at $93,000 – Only 2,000 Patients Will Get it in First Year

» 29 April 2010 » In Dendreon, Prostate Cancer, Provenge, Vaccines » Comments Off

Dendreon is pricing Provenge high and for the first year its availability will be low, according to a report today in Xconomy, a Seattle business website. Provenge, the first immunotherapy to win FDA approval for treatment of men with prostate cancer, will cost $93,000 per patient. Only 2,000 patients will be treated with Provenge in the first year.

Continue reading...

FDA Approves PROVENGE ® for the Treatment of Men with Advanced Prostate Cancer

» 29 April 2010 » In Cancer, FDA, Prostate Cancer, Provenge, Vaccines » Comments Off

SEATTLE, April 29, 2010 –Dendreon Corporation (Nasdaq: DNDN) today announced that the U.S. Food and Drug Administration (FDA) has approved PROVENGE(®) (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC). Provenge is designed to induce an immune response against Prostatic Acid Phosphatase (PAP), an antigen expressed in most prostate cancers, and is the first in a new therapeutic class known as autologous cellular immunotherapies.

Continue reading...

U.S. cancer trials near state of crisis, report

» 16 April 2010 » In Cancer, Cancer research, clinical trials conduct of » Comments Off

The U.S. government’s cancer research network is in severe disarray according to a report by the Institute of Medicine. Waste and inefficiency cause 40% of all late-stage government funded cancer trials to be abandoned before completion, the report found. Shannon Pettypiece at Bloomberg.com and Liz Jones at FierceBiotech say the report paints a doomladen picture.

“The system used to conduct cancer clinical trials in the U.S. is ‘approaching a state of crisis,’ with waste and inefficiency creating difficulties for those wanting to undertake these studies,” Jones writes.

Continue reading...

Phase 3 Trial Underway for MDV 3100 for Advanced Prostate Cancer

» 15 April 2010 » In Cancer, Clinical trials, MDV 3100, Metastatic, Prostate Cancer, trial results » Comments Off

In light of favorable results from the Phase 1-2 trial of MDV 3100 for advanced prostate cancer, a Phase 3 trial is enrolling at sites in the US, Canada, South America, UK, Europe, Australia, and South Africa. Results from the earlier trial are published online by the UK medical journal The Lancet.

Continue reading...

A Mural for a Cancer Patient Tells a Story of Broken Healthcare

» 09 November 2009 » In Awareness Events, Cancer, Healthcare Reform » Comments Off

Regina Holliday prepares her supplies for a day of painting. Photo by Maggie Starbard, NPR.

Regina Holliday prepares her supplies for a day of painting. Photo by Maggie Starbard, NPR.

Regina Holliday has painted a mural on the side of a gas station in Washington DC to tell the story of a day in her husband Fred’s struggle with broken healthcare. At ge 39, Fred was diagnosed with stage IV kidney cancer.

Continue reading...

Free Prostate Screening in Seattle November 20

» 05 November 2009 » In Prostate Cancer » Comments Off

Seattle Prostate Institute, an affiliate of Swedish Cancer Institute, is offering free prostate cancer screening tests on Fri., Nov. 20 between 8 a.m. and 3:30 p.m. at their offices in the 1101 Madison Medical Tower, Suite 1101, on the Swedish/First Hill Campus.

Continue reading...

ASTRO Prostate Cancer News Headlines Preview

» 31 October 2009 » In Beam Radiation, PCa Treatments, Prostate Cancer, Proton » Comments Off

The American Society for Radiation Oncology (ASTRO) will host news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting to be held this coming week in Chicago. Prostate cancer features in three of briefings. Here are the headlines:

Continue reading...

Tags:

Obama Orders Medical Marijuana Use Allowed Where State Law Makes it Legal

» 19 October 2009 » In Cancer, Legal » Comments Off

The Obama administration has changed Federal policies on regulation of medical marijuana use under state law. During his presidential race last year, Barack Obama said that he intended to halt raids of medical marijuana facilities operating legally under state laws. Today, new Justice Department guidelines brought this change about.

The new guidelines order federal drug agents to stop arresting or charging patients, caregivers or suppliers who are dispensing, buying or using marijuana for medical purposes allowed by state law.

Continue reading...

Tags: ,

Page 1 of 812345...7Last »»